Biliary Tract Cancers (BTC) Market Size Anticipated to Soar During the Forecast Period 2021-30 at a CAGR of 11.69% in the 7MM, Projects DelveInsight
Erdafitinib (Janssen Research and Development). The anticipated launch of targeted therapies including potential FGFR gene fusions and somatic mutations in IDH 1/2 in iCCA, PRKACA or PRKACB gene fusions in pCCA, and ELF3 mutations in dCCA/ampullary carcinoma shall push the growth of the BTC market size in the offing. Further, an increase in the BTC incidence, increment in healthcare spending, extensive R&D along better awareness of cancer is expected to give the BTC market size growth a muc...
United States United Kingdom Innovent Biologics Roche Ipatasertib Prnewswire Delveinsight Chia Tai Tianqing
Source: prnewswire.com